Relationship between the expression of MDM2 protein, p53 protein and non-Hodgkin lymphoma in childhood

( views:, downloads: )
Author:
LIU Zhuang()
HAN Yun-li()
WEI Hong-ying()
LI Shu-quan()
Journal Title:
JOURNAL OF LEUKEMIA & LYMPHOMA
Issue:
Volume 15, Issue 04, 2006
DOI:
Key Word:

Abstract:

  • [1]Juven-Gershon T,Oren M.MDM2:the ups and downs[J].Mol Med,1999,5(2):71-83.
  • [2]Onel K,Cardon-Cardo C.MDM2 and prognosis[J].Mol Cancer Res,2004,2(1):1-8.
  • [3]Haupt Y,Maya R,Kazaz A,et al.MDM2 promotes the rapid degradation of p53[J].Nature,1997,387(6630):296-299.
  • [4]Wilda M,Bruch J,Harder L,et al.Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children[J].Leukemia,2004,18(3):584-588.
  • [5]Moller M B,Nielsen O,Pedersen T,et al.Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin Lymphoma entities[J].Mod Pathol,1999,12(11):1010-1016.
  • [6]Watanabe T,Hotta T,Ichikawa A,et al.The MDM2 oncogene overpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin[J].Blood,1994,84(9):3158-3165.
  • [7]Sanchez E,Chacon I,Plaza M M,et al.Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulation proteins[J].J Clin Oncol,1998,16(5):1931-1939.
  • [8]刘壮,龙桂芳,韩蕴丽,等.MDM2的表达与儿童非霍奇金淋巴瘤关系的研究[J].中华儿科杂志,2004,42(12):928-931.
  • [9]Tai Y C,Tan J M A,Pet S C.Higher frequency of p53 gene mutations in diffuse large B-cell lymphoma with MALT component[J].Pathology international,2004,54(11):811-815.
  • [10]Ichikawa A,Kinoshita T,Watanabe T,et al.Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma[J].New Engl J Med,1997,337(8):529-534.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn